

Our evolution will continue with broader offerings to the markets we serve and stronger solutioning of our unique value to the very specific needs of our clients. Company Achieves 1.5 Billion Valuation CHICAGO, NEW YORK, LONDON and HONG KONG, Janu Enfusion, a global leader in investment management technology solutions and services, announced that it has received a 150 million minority investment from ICONIQ Growth. In line with Enfusions continued profitability and growth, this funding values the Company at 1.5 billion. Despite significant obstacles (many that we’ve all had to face), we built a significantly stronger and more strategic business globally by further focusing every effort on the current and future needs of our clients in the asset management community. The funding is an endorsement of Enfusions pioneering cloud-native SaaS approach to breaking technological barriers and removing informational and operational constraints for its investment management clients. Securities and Exchange Commission that the company and certain pre-IPO investors plan to offer the public roughly 18.8M Class A shares within a 15-17/share range.
#ENFUSION ICONIQ SOFTWARE#
Enfusion (ENFN) wrote in a revised S-1 filed with the U.S. Notes: (1) Includes all software IPOs across all ICONIQ Growth portfolio including. 2021 was such a tremendous year in so many ways - one that was defined by our massive growth, our resilience, our teamwork, our determination and our grit. (ENFN) released specifics Tuesday for an IPO thats expected to value the fintech at some 1.9B. The Company crossed the 100M ARR milestone this year and is now listed as a public company on the New York Stock Exchange. Enfusion launched its first products in 2006 when founders Tarek Hammoud, Stephen Malherbe and Scott Werner, addressed foundational issues in the legacy technology stacks available for fund. More than 1/3rd of these clients were acquired since the beginning of 2020.

As we (just) begin 2022, I took the opportunity to reflect on the Enfusion success of 2021, our IPO, and our very bright future. Enfusion today now features 635 clients and a team of over 600 people around the world.
